Tumor-like Cerebral Perivasculitis in a Pediatric Patient with Systemic Lupus Erythematosus  by Huang, Ching-Hua et al.
Kaohsiung J Med Sci April 2008 • Vol 24 • No 4218
© 2008 Elsevier. All rights reserved.
Systemic lupus erythematosus (SLE) is characterized
by autoantibodies against self-antigens and resulting
damage to various organ systems. Central nervous
system (CNS) involvement causes major morbidity
and mortalities, and could be presented as a wide spec-
trum of neurologic and psychiatric features. Clinical
manifestations range from severe neurologic dysfunc-
tion, such as stroke or transverse myelitis, to subclin-
ical abnormalities in neurocognitive function, such as
memory, intellect, and learning problems [1]. The fre-
quency of neuropsychiatric presentations in SLE has
been estimated at around 25–70% [2].
Recently the American College of Rheumatology
(ACR) formulated specific criteria for neuropsychiatric
lupus (NPSLE). It provides standards and diagnostic
testing recommendations for 19 different neuropsy-
chiatric syndromes [3]. However, the diagnosis and
management of NPSLE remain challenges for clinical
practitioners.
Here, we report the case of a 14-year-old SLE male
patient with regular steroid control for his lupus
nephritis, who presented with consciousness changes.
A huge brain mass lesion was found by magnetic res-
onance imaging (MRI) and surgical decompression
was performed. The brain biopsy revealed cerebral
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Nervous system manifestations are present in up to 70% of patients with systemic lupus erythe-
matosus (SLE). The spectrum of clinical symptoms varies widely, from severe, life-threatening
symptoms at presentation, such as transverse myelitis, to symptoms of more subtle and subclinical
abnormalities of neurocognitive function. We report the case of a 14-year-old patient with SLE and
lupus nephritis under regular steroid therapy, who had a sudden onset of consciousness change.
Brain magnetic resonance imaging showed a huge mass lesion. After surgical decompression and
corticosteroid pulse therapy, the patient’s neurologic symptoms improved dramatically. Brain
biopsy revealed perivasculitis of the brain with marked perivascular infiltration of eosinophils,
macrophages, and neutrophils. Microhemorrhage was also evident. The patient recovered without
obvious neurologic sequelae.
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perivasculitis with eosinophil, macrophage and neu-
trophil infiltration. The patient recovered without
significant neurologic sequelae.
CASE PRESENTATION
A 14-year-old male was admitted in a subcomatous
condition. According to his family, he had suffered
from SLE for 3 years with an initial presentation of
arthralgia of the shoulder, knee, the proximal inter-
phalangeal joints and metacarpophalangeal joints of
both hands. Neutropenia, thrombocytopenia, positive
antinuclear antibody (ANA), proteinuria, and anti-
double-stranded DNA were noted at that time. The
patient was treated with regular corticosteroid (pred-
nisolone). Arthralgia, neutropenia, and thrombocy-
topenia improved, but proteinuria progressed. Daily
protein loss from urine was up to 15.3 g/day. Renal
biopsy showed lupus nephritis, class V. Corticosteroid
pulse therapy twice and chemotherapy with cyclophos-
phamide six times were given for lupus nephritis. As
the proteinuria improved, the dose of prednisolone
was tapered to 5 mg every other day.
Mild headache, cough, rhinorrhea, decreased appe-
tite, and lethargy were noted for 2 days, then he was
sent to our emergency department. Initial physical
examination showed a Glasgow coma scale rating of
eye opening 4, verbal response 5, and motor response
6, as well as intact mentality. General weakness and
lethargy were noted. The patient’s body temperature
and blood pressure were within the normal range.
Both pupils were normal in size and reacted slowly
to light stimulation. Muscle power assessment and
neurologic examination including Kernig’s sign and
Babinski’s sign were normal. However, the patient
was unable to remain standing for several minutes.
He was then admitted to our pediatric intensive care
unit. Laboratory tests showed normal peripheral white
blood cell counts, C-reactive protein level, erythrocyte
sedimentation rate, serum glucose level, and elec-
trolytes. Serologic tests showed the following results:
ANA titer>1:1,280; anti-double-stranded DNA, 23IU/
mL; C3, 117.0mg/dL (normal, 83–201mg/dL); and C4,
11.4 mg/dL (normal, 16–47 mg/dL). Prothrombin time
and partial thromboplastin time were within normal
limits. The patient’s headache became worse after ad-
mission and physical examination showed right pupil
enlargement without a light reflex and paralysis of the
left-side limbs. Subsequently, consciousness was lost.
A left-sided Babinski’s sign was also present.
Computed tomography of the brain was arranged
immediately and revealed a huge lobulated mass lesion
about 70 × 42 mm over the right temporal lobe (Figure
1A). Midline shift, brainstem compression, and ob-
structive hydrocephalus were also noted. Glycerol and
BA
Figure 1. (A) Brain computed tomography shows an isodense mass with a hypodense rim in the right temporal lobe (arrow). (B) Brain mag-
netic resonance imaging shows focal swelling with internal streaks of hemorrhage over the right temporal lobe with a mass effect that caused
medial herniation of the uncus, which resulted in compression of the midbrain. The size of the local swelling is about 7 × 42 mm (arrow).
Kaohsiung J Med Sci April 2008 • Vol 24 • No 4220
C.H. Huang, C.H. Hung, Y.T. Chu, and Y.M. Hua
corticosteroid were administered to reduce increased
intracranial pressure and swelling of the brain. Brain
MRI was then performed and showed focal swelling
with internal streaks of hemorrhage over the right tem-
poral lobe and medial herniation of the uncus caused
by the mass effect, resulting in compression of the mid-
brain and the size of the local swelling measured about
70 × 42 mm (Figure 1B). Magnetic resonance angiog-
raphy (MRA) of the intracranial vessels showed nor-
mal vessel calibers and blood flows of the circle of
Willis. Since herpes encephalitis could not be ruled
out, acyclovir was given for the treatment of herpes
simplex virus (HSV) infection. Corticosteroid pulse
therapy was also administered.
A neurosurgeon was consulted and surgical decom-
pression with right temporal craniotomy was per-
formed. The operation revealed spotted hemorrhage
on brain tissue with a hematoma in the temporal area.
The cerebrospinal fluid was examined and showed
elevated red blood cell counts and normal protein
level. Brain biopsy demonstrated perivasculitis of the
brain with marked perivascular infiltration of eosino-
phils, macrophages, neutrophils, and evident micro-
hemorrhage (Figure 2). An HSV polymerase chain
reaction produced a negative finding and acyclovir
was therefore discontinued.
The symptoms of limb paralysis, pupil dilatation,
and lethargy resolved 5 days after the operation.
Hemolytic anemia and thrombocytopenia were noted
3–4 days after admission. Direct and indirect Coombs’
tests were positive. However, tests for antiplatelet
antibody, antiphospholipid antibodies and lupus anti-
coagulant were all negative. Plasmapheresis was then
performed to remove the autoantibody and the hemo-
lysis improved gradually. Jaundice was not observed
during the subsequent days. The patient was dis-
charged from our hospital in a stable condition without
obvious neurologic sequelae.
DISCUSSION
Involvement of the CNS is one of the major causes 
of morbidity and mortality in patients with SLE [4].
The pathogenesis of CNS SLE may be divided into
four categories: immune complex vasculitis; neuron-
reactive autoantibodies; thrombosis associated with
antiphospholipid antibodies; and cytokine-enhanced
autoimmunity [2,5,6]. Neurologic manifestations in-
clude psychosis, seizure, chorea, stroke, cranial nerve
involvement, paralysis, cognitive impairment, cere-
bellar ataxia, headache, and organic brain lesion [2].
Patients with CNS SLE vary widely in their spectrum
of CNS manifestations. The range is from those with
severe, life-threatening conditions at presentation, such
as transverse myelitis or stroke, to those with more
subtle and subclinical abnormalities of neurocognitive
function [1]. The most common manifestations of focal
CNS disease in SLE patients are transient ischemic
attacks and ischemic stroke.
In order to improve the diagnosis of neuropsychi-
atric manifestation of SLE, the American College of
Rheumatology (ACR) published the diagnostic defi-
nition of NPSLE in 1999 [3]. It provides not only the
criteria for each neuropsychiatric symptom, but also
the recommendations for laboratory and image stud-
ies. These definitions have been applied and used for
epidemiology studies, but they are still far from per-
fect [7]. The most problematic cases encountered are
the mildest and the most subjective of the syndromes.
Although neuropathologic studies are limited in the
literature, vasculopathy and microinfarcts have been
noted in several studies [8]. However, cerebral perivas-
culitis had not been reported and the manifestation as
tumor-like CNS lesion in our patient is very rare in
the review of the literature.
One of the most important advances in the treat-
ment of CNS lupus has come from the recognition of
the antiphospholipid syndrome, a prothrombotic dis-
ease, and recognition of the importance of thrombotic
Figure 2. Histopathology of brain tissue obtained during the
operation. Microscopically, the section shows brain perivasculitis
with marked perivascular infiltration of eosinophils, macrophages
and neutrophils. Brain microhemorrhage is also evident. The
inflammatory response was nonspecific.
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mechanisms in the development of a number of CNS
manifestations in SLE patients [9]. Elevated titers of
anticardiolipin Abs (aCL) were reported most often
and found in patients with cognitive impairment, psy-
chosis, depression, seizures, chorea, and migraine.
Antiphospholipid antibodies were positive in 70% of
all SLE patients [10]. The only significant association
between neuropsychiatric symptoms and aPL was for
CVA and IgM anticardiolipin antibodies [10]. Control
of symptoms and the cessation of immune-complex
and cytokine production, as well as the development
of thrombosis, may be the goal of treatment. High-
dose oral prednisolone or intravenous methylpred-
nisolone infusions are indicated for acute severe CNS
manifestations. Pulse intravenous cyclophosphamide
therapy may help when severe manifestations are re-
fractory to corticosteroids and other immunosuppres-
sive agents [11,12]. Plasmapheresis can remove free
antibodies, complement components, and circulating
immune complexes [4].
Quantitative MRI offers increased sensitivity for
detecting subtle brain damage. In early studies, a cor-
relation of such subtle brain damage with cognitive
dysfunction and evidence that it is a prognostic indi-
cator has been demonstrated [13]. Patients with CNS
lupus may undergo MRI to differentiate inflamma-
tory lesions from ischemic damage, or to detect early
brain lesions. Our patient suffered from a sudden
onset of consciousness change and had a huge mass
lesion detected by MRI. High-dose corticosteroid ther-
apy was initiated early for a short time. After surgical
decompression, the patient’s neurologic symptoms
improved, and he recovered without obvious neuro-
logic sequelae. The most likely explanation for the
clinical and histopathologic findings is vasculitis due
to SLE.
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